BG29287A3 - Method of obtaining of substituated 6- phenyl- 1, 2, 4- triazol (4, 3- b)- pyridazin - Google Patents

Method of obtaining of substituated 6- phenyl- 1, 2, 4- triazol (4, 3- b)- pyridazin

Info

Publication number
BG29287A3
BG29287A3 BG037371A BG3737177A BG29287A3 BG 29287 A3 BG29287 A3 BG 29287A3 BG 037371 A BG037371 A BG 037371A BG 3737177 A BG3737177 A BG 3737177A BG 29287 A3 BG29287 A3 BG 29287A3
Authority
BG
Bulgaria
Prior art keywords
phenyl
substituated
pyridazin
triazol
obtaining
Prior art date
Application number
BG037371A
Other languages
Bulgarian (bg)
Inventor
George Allen
John Hanifin
Daniel Moran
Jay Albrighn
Original Assignee
American Cyanamid Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/725,597 external-priority patent/US4230705A/en
Application filed by American Cyanamid Company filed Critical American Cyanamid Company
Publication of BG29287A3 publication Critical patent/BG29287A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/08Preparation of carboxylic acids or their salts, halides or anhydrides from nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/08Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/12Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Метод за получаване на охарактеризирани и доказани в описанието субституирани -6-фенил-1,2,4 -триазоло-(4,3-в)-пиридазини с формула........... Патентните претенции са формулирани в 5 точкиA method for the preparation of characterized and proven in the description substituted -6-phenyl-1,2,4-triazolo-(4,3-c)-pyridazines of formula........... The patent claims are formulated in 5 points

BG037371A 1976-09-22 1977-09-20 Method of obtaining of substituated 6- phenyl- 1, 2, 4- triazol (4, 3- b)- pyridazin BG29287A3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US05/725,597 US4230705A (en) 1976-09-22 1976-09-22 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazines and their uses in treating anxiety
US73039576A 1976-10-07 1976-10-07
US73547576A 1976-10-26 1976-10-26

Publications (1)

Publication Number Publication Date
BG29287A3 true BG29287A3 (en) 1980-10-15

Family

ID=27419081

Family Applications (1)

Application Number Title Priority Date Filing Date
BG037371A BG29287A3 (en) 1976-09-22 1977-09-20 Method of obtaining of substituated 6- phenyl- 1, 2, 4- triazol (4, 3- b)- pyridazin

Country Status (19)

Country Link
JP (1) JPS5340798A (en)
AR (2) AR218036A1 (en)
AT (1) AT360034B (en)
AU (1) AU513760B2 (en)
BG (1) BG29287A3 (en)
CA (1) CA1080712A (en)
DD (1) DD132586A5 (en)
DE (1) DE2741763A1 (en)
DK (1) DK417377A (en)
ES (3) ES462543A1 (en)
FI (1) FI772802A (en)
FR (1) FR2442848A1 (en)
GB (1) GB1589237A (en)
GR (1) GR71699B (en)
LU (1) LU78150A1 (en)
NL (1) NL7710389A (en)
NO (1) NO773245L (en)
PT (1) PT67067B (en)
RO (1) RO72226A (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR70309B (en) * 1979-10-29 1982-09-08 Dow Chemical Co
FR2473522A1 (en) * 1980-01-16 1981-07-17 Synthelabo NOVEL DIHYDRO-2,3 IMIDAZO (1,2-B) PYRIDAZINE SUBSTITUTED DERIVATIVES AND MEDICAMENTS, PARTICULARLY USEFUL AS ANTIDEPRESSANTS, CONTAINING THEM
EP0036711B1 (en) * 1980-03-22 1985-12-04 Fbc Limited Pesticidal heterocyclic compounds, processes for preparing them, compositions containing them, and their use
DE3217325A1 (en) * 1982-05-08 1983-11-10 Hoechst Ag, 6230 Frankfurt 3-AMINO-6-ARYL-1,2,4-TRIAZOLO (4,3-B) -PYRIDAZINE, THEIR PRODUCTION AND USE
US4487930A (en) * 1982-09-07 1984-12-11 The Dow Chemical Company 6-[(Cyclic amino)alkylamino]-tetrahydrotriazolo[3,4-a]phthalazines
FR2562071B1 (en) * 1984-03-30 1986-12-19 Sanofi Sa TRIAZOLO (4,3-B) PYRIDAZINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US4767765A (en) * 1985-10-31 1988-08-30 American Cyanamid Company N-substituted-N-[3-(1,2,4-triazolo-[4,3-b]pyridazin-6-yl)phenyl]alkanamides, carbamates and ureas
US4654343A (en) * 1985-10-31 1987-03-31 American Cyanamid Company N-substituted-N[3-(1,2,4-triazolo[4,3-b]pyridazin-6-yl)phenyl]alkanamides, carbamates and ureas
PL331072A1 (en) * 1996-07-25 1999-06-21 Merck Sharp & Dohme Substututed derivatives of triazolo-pyrydazine as ligands for gaba receptors
AU746866B2 (en) 1998-01-14 2002-05-02 Merck Sharp & Dohme Limited Triazolo-pyridazine derivatives as ligands for GABA receptors
GB9801234D0 (en) * 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801202D0 (en) * 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801208D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
EA002755B1 (en) 1998-01-21 2002-08-29 Мерк Шарп Энд Домэ Лимитед Triazolo-pyridazine derivatives as ligands for gaba receptors
GB9801210D0 (en) * 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801397D0 (en) * 1998-01-22 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801538D0 (en) 1998-01-23 1998-03-25 Merck Sharp & Dohme Pharmaceutical product
WO2005077953A1 (en) * 2004-02-18 2005-08-25 Banyu Pharmaceutical Co., Ltd. Nitrogenous fused heteroaromatic ring derivative
FI3548033T3 (en) * 2016-11-28 2024-07-10 Praxis Prec Medicines Inc Compounds and their methods of use
SG11202011879RA (en) 2018-05-30 2020-12-30 Praxis Prec Medicines Inc Ion channel modulators
US11773099B2 (en) 2019-05-28 2023-10-03 Praxis Precision Medicines, Inc. Compounds and their methods of use
US11505554B2 (en) 2019-05-31 2022-11-22 Praxis Precision Medicines, Inc. Substituted pyridines as ion channel modulators

Also Published As

Publication number Publication date
PT67067B (en) 1979-02-19
FR2442848A1 (en) 1980-06-27
AU513760B2 (en) 1980-12-18
DK417377A (en) 1978-03-23
AR217886A1 (en) 1980-04-30
CA1080712A (en) 1980-07-01
FI772802A (en) 1978-03-23
LU78150A1 (en) 1978-01-23
AU2899577A (en) 1979-03-29
DD132586A5 (en) 1978-10-11
GB1589237A (en) 1981-05-07
JPS5340798A (en) 1978-04-13
ES477799A1 (en) 1980-04-01
RO72226A (en) 1982-09-09
AR218036A1 (en) 1980-05-15
AT360034B (en) 1980-12-10
ES462543A1 (en) 1979-06-16
ATA677577A (en) 1980-05-15
DE2741763A1 (en) 1978-03-23
NL7710389A (en) 1978-03-28
GR71699B (en) 1983-06-21
PT67067A (en) 1977-10-01
ES477800A1 (en) 1979-10-16
NO773245L (en) 1978-03-28

Similar Documents

Publication Publication Date Title
BG29287A3 (en) Method of obtaining of substituated 6- phenyl- 1, 2, 4- triazol (4, 3- b)- pyridazin
BG37375A3 (en) Method for preparing prolinic derivatives
BG28053A4 (en) Method of obtaining of aminoalkyl-heterocycles
BG28061A3 (en) Method of obtaining of hexahydrodibenzopyranones
BG34338A3 (en) Method for obtaining thiadiazolylcephalosporines
BG32850A3 (en) Method for obtaining of 6 a, 10 a- cis- hexahydrodibenzopyranols
BG28712A3 (en) Method of obtaining of substituated in 11- a position 5,11- dihydro- 6h- pyrido (2,3-b) (1,4) benzodiazepine- 6- ons
BG28068A3 (en) Method of obtaining of 3-chlorcephalosporines
BG28072A4 (en) Method of obtaining of 1-substitvated canamyzine derivatives
BG28711A3 (en) Method of obtaining of substituated in 11- a position 5,11- dihydro-6h- pyrido (2,3- b) (1,4) benzodiazepine- 6- ons
BG28713A3 (en) Method of obtaining of 5,11- dihydro- 6h- pyrido (2,3- b) (1,4) benzodiazepine- 6- ons
BG32856A3 (en) METHOD OF OBTAINING 1-OXADETYLACEPHALOSPORIUM
BG35464A3 (en) Method preparing fluorene derivatives
BG31073A3 (en) Method for obtaining of 1, 5- substituated- 2- pyrolidine
BG34038A3 (en) A method of obtaining 7- substituted aminoacetamidooxadetiacephalosprorines
BG28064A3 (en) Method of obtaining of 2,6-methane-2h-1-benzoxozines
BG30927A3 (en) Method for obtaining of trans- 4- alpha- phenyl- octahydro- 1h- 2- pyridine
BG36630A3 (en) Method for preparing substituted diphenylic ethers
BG36935A3 (en) Method for preparing benzodiazepine compounds
BG28845A3 (en) Method of obtaining of n- alkyldiphenylamines
BG28416A4 (en) Method of obtaining of benzo (c) hinolines
BG28055A3 (en) Method of obtaining of phenylperazine derivatives
BG35032A3 (en) Method for preparing 1, 1, 2- triphenylpropene derivatives
BG28066A3 (en) Method of obtaining of pyridobenzodiazepinones
BG33436A3 (en) Method for obtaining of 4- dezacetyl- vinblastine- 3- spiro- 5"- oxazolidin- 2", 4"- dion